Article Information
History
- September 1, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jean-Louis GEORGES1,5 (jgeorges{at}ch-versailles.fr),
- Floriane Floriane Gilles1 (fgilles{at}ch-versailles.fr),
- Helene Cochet1 (hcochet{at}ch-versailles.fr),
- Alisson Bertrand1 (alissonbertrand7{at}gmail.com),
- Marie De Tournemire1 (marie.detournemire{at}yahoo.fr),
- Victorien Monguillon1 (victorienmonguillon{at}hotmail.fr),
- Maeva Pasqualini1 (maevapasqualini{at}gmail.com),
- Alix Prevot1 (a.prevotharen{at}gmail.com),
- Guillaume Roger1 (rog.guillaume{at}gmail.com),
- Joseph Saba1 (josaba{at}hotmail.fr),
- Josephine Soltani1 (soltani.josephine{at}gmail.com),
- Mehrsa Koukabi-Fradelizi2 (mkoukabi{at}ch-versailles.fr),
- Jean Paul Beressi3 (jpberessi{at}ch-versailles.fr),
- Cecile Laureana4 (claureana{at}ch-versailles.fr),
- Jean François Prost1 (jf.prost78{at}me.com) and
- Livarek Bernard1 (blivarek{at}ch-versailles.fr)
- 1 Cardiology department, Centre Hospitalier de Versailles, Le Chesnay, France;
- 2 Emergency department, Centre Hospitalier de Versailles, Le Chesnay, France;
- 3 Department of endocrinology and diabetology, Centre Hospitalier de Versailles, Le Chesnay, France;
- 4 Department of medical information and public health, Centre Hospitalier de Versailles, Le Chesnay, France
- ↵* Corresponding author; email: jgeorges{at}ch-versailles.fr
Posted September 01, 2020.
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
